Reports

Ideas That Generate Results

Global Vaccine Market Forecast to 2013

Global Vaccine Market Forecast to 2013

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Nov, 2011| No. of Pages : 140

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1700.00
Hard Copy Mail Delivery
US$ 1700.00
Electronic Access - Multi-User License
US$ 2000.00

1. Analyst View

2. Research Methodology

3. Market Overview

4. Key Market Drivers
     4.1 Improved Routine Immunization
     4.2 Emerging Markets
     4.3 Technological Developments
     4.4 Investment in Vaccine Research

5. Emerging Trends
     5.1 DNA Vaccines: Gaining Popularity
     5.2 M&As in Vaccine Market
     5.3 Vaccine Delivery Advancements

6. Pediatric Vaccines
     6.1 Pneumococcal
     6.2 Polio
     6.3 Varicella
     6.4 Meningococcal
     6.5 Rotavirus
     6.6 DTP
     6.7 Measles, Mumps & Rubella (MMR)
     6.8 Tuberculosis

7. Adult/Travel & Therapeutic Vaccines
     7.1 Hepatitis B
     7.2 Malaria
     7.3 Yellow Fever
     7.4 Rabies
     7.5 Japanese Encephalitis
     7.6 Typhoid
     7.7 West Nile
     7.8 HIV
     7.9 Cancer
     7.10 Influenza

8. Key Geographical Markets
     8.1 US
            8.1.1 Market Overview
            8.1.2 Key Players
            8.1.3 Product Portfolio
     8.2 Europe
            8.2.1 Market Overview
            8.2.2 Key Players
            8.2.3 Product Portfolio
     8.3 China
            8.3.1 Market Overview
            8.3.2 Key Players
            8.3.3 Product Portfolio
     8.4 India
            8.4.1 Market Overview
            8.4.2 Key Players
            8.4.3 Product Portfolio
     8.5 Japan
            8.5.1 Market Overview
            8.5.2 Key Players
            8.5.3 Product Portfolio
     8.6 Brazil
            8.6.1 Market Overview
            8.6.2 Key Players
            8.6.3 Product Portfolio

9. Restraints in Vaccine Industry
     9.1 High R&D Cost
     9.2 Lack of Infrastructure for Trials and Manufacturing
     9.3 Vaccine Supply
     9.4 Ineffective Distribution

10. Competitive Landscape
     10.1 Sanofi-Aventis
     10.2 Novartis
     10.3 GSK
     10.4 Pfizer
     10.5 Merck & Co.

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.